World Health Organization Issues Concern Over Critical Scarcity of Weight-Loss Jabs
Under one in 10 patients who could benefit from weight-loss injections such as Wegovy can access them, caution the World Health Organization as it releases its inaugural guidance on the drugs.
With over a billion people worldwide now living with obesity, it is urging increased and just availability to this class of drugs.
According to forecasts, over two billion will be living with obesity by 2030 without intervention.
"Our latest guidelines affirms that excess weight is a long-term condition that can be treated with holistic and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are major obstacles to widespread access to the injections that can assist patients in reducing substantial body mass, says the organization.
Skinny Jab Shortage
Even in the current most favorable case, the supply of GLP-1 therapies would only suffice for around 100 million people – fewer than 10% of the global need, per the WHO.
The advice encourages governments and firms to increase availability, via approaches such as patent sharing.
Exclusive production rights on the active ingredient – the core component of the drug Wegovy – is set to lapse in a number of nations in 2026.
How Weight-Loss Drugs Operate
GLP-1 drugs imitate a biological compound to reduce digestion speed, suppress the appetite and enhance satiety so people consume fewer calories.
Individuals commonly see weight reduction after several weeks of beginning the weekly injections.
Evidence indicates patients may put most of the weight back on after a year of stopping the drug, as their normal food cravings come back.
Being overweight or obese increases your likelihood for contracting health problems, including type 2 diabetes, cardiovascular issues, stroke, and some cancers.
Obesity affects people in every country and was linked to over three and a half million fatalities worldwide in 2024, per the health agency.
